Clinical

ALMB-0166, the first Cx43-hemichannel antibody, given as a single dose to 24 SCI patients: adverse events matched placebo, 1200/2400mg improved scores, two reached AIS E. A small, exploratory result.

A narrative review of knee injections, corticosteroids to exosomes: an RCT tying repeated triamcinolone to cartilage loss, and the evidence-maturity gap across PRP, orthobiologics, MSCs, exosomes.

Neurogenic bladder afflicts more than 80% of people with spinal cord injury. A careful reading of a preclinical study reporting that the anti-RGMa antibody elezanumab improved voiding function and neuroplasticity in rats. Efficacy in humans has not yet been shown.

Hello, and welcome to everyone interested in the latest advances in heart disease treatment! Today we focus on an innovative surgical technique called TAVR (Transcatheter Aortic Valve Replacement).

Heart health greatly affects our quality of life, but a progressive disease called ATTR cardiac amyloidosis threatens it. This article explains the basics of ATTR amyloidosis and focuses on Patisiran.

The paper introduced here is the following. Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with